 AUSTIN, Texas, March 18, 2021 GLOBE NEWSWIRE -- Molecular Templates, Inc. Nasdaq: MTEM, Molecular Templates, or MTEM, a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, engineered toxin bodies ETBs, today reported financial results for the fourth quarter of 2020. 